Giant papillary conjunctivitis: A review

Acta Ophthalmologica Scandinavica, Supplement

Volumn 77, Issue 228, 1999, Pages 17-20

  Katelaris, C H ^a  

^a WESTMEAD HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CROMOGLYCATE DISODIUM; IMMUNOGLOBULIN E; LODOXAMIDE; LOTEPREDNOL ETABONATE; NEDOCROMIL; OLOPATADINE;

ALLERGY; CATARACT; CONFERENCE PAPER; CONTACT LENS; CORNEA DISEASE; CORNEA EROSION; DISPOSABLE EQUIPMENT; EYE INJURY; FOREIGN BODY REACTION; HISTOPATHOLOGY; HUMAN; HYPEREMIA; IMMUNITY; INFECTION; INTRAOCULAR HYPERTENSION; KERATOCONJUNCTIVITIS; MUCUS SECRETION; MYDRIASIS; PAPILLARY CONJUNCTIVITIS; PATIENT CARE; PATIENT EDUCATION; PERSONAL HYGIENE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSTHESIS; PRURITUS; SUTURING METHOD; SYMPTOMATOLOGY; TOPICAL DRUG ADMINISTRATION; VISUAL IMPAIRMENT; ALLERGIC CONJUNCTIVITIS; ANIMAL; REVIEW;

ANIMALS; CONJUNCTIVITIS, ALLERGIC; HUMANS;

EID: 0032586309     PISSN: 13953931     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0420.1999.tb01166.x     Document Type: Conference Paper

References (17)

1. Spring TF (1974): Reaction to hydrophilic lenses. Med J Aust 1: 449-450.
2. Allansmith MR, Korb DR et al. (1977): Giant Papillary Conjunctivitis in contact lens wearers. Am J Ophthalmol 83: 697-000.
3. Meisler DM & Keller WB (1995): Contact lens type, material, and deposits in giant papillary conjunctivitis. CLAO Journal, January 21(1): 77-79.
4. Ballow M, Donshik P, Rapacz P et al. (1989): Immune responses in monkeys to lenses from patients with contact lens-induced giant papillary conjunctivitis. CLAO Journal 15: 64.
5. Richard NR, Anderson JA et al. (1992): Evaluation of tear protein deposits on contact lenses with patients with and without giant papillary conjunctivitis. CLAO Journal July 18(3): 143-147.
6. Elgebaly SA, Donshik PC, Rahhl F & Williams W (1991): Neutrophil chemotactic factors in the tears or giant papillary conjunctivitis patients. Invest Ophthalmol Vis Sci 32: 208-213.
7. Hardman Lea SJ, Neugebeaur MAZ et al. (1990): The incidence of ophthalmic problems in the contact lens wearing population. Eye 4: 706-711.
8. Allansmith MR, Korb DR & Greiner, JV (1978): Giant Papillary Conjunctivitis induced by hard or soft contact lens wear. Quantitative histology. Ophthalmology 85: 766.
9. Montan PG & Van Hage-Hamsten M (1996): Eosinophil cationic protein in tears in allergic conjunctivitis. Br J Ophthalmol 80: 556-560.
10. Trocme SD, Kephart GM, Allansmith MR et al. (1989): Conjunctival deposition of eosinophil granule major basic protein in vernal keratoconjunctivitis and contact lens-associated giant papillary conjunctivitis. Am J Ophthalmol 108: 57-63.
11. Sengor T, Irkec M et al. (1995): Tear LTC4 levels in patients with sub-clinical contact lens related giant papillary conjunctivitis. CLAO Journal 21(3): 159-163.
12. Ballow M, Donshik PC & Mendelson L (1985): Complement proteins and c3 anaphylatoxin in the tears of patients with conjunctivitis. J Allergy Clin Immunol 76: 473-476.
13. Metz DP, Bacon AS, Holgate S & Lightman SL (1996): Phenotypic characterisation of T-cells infiltrating the conjunctiva in chronic allergic eye disease. J Allergy Clin Immunol 88: 686-696.
14. Meisler DM, Zaret CR & Stock, EL (1989): Trantas' dots and limbal inflammation associated with soft contact lens wear. Am J Ophthalmol 89: 66-69.
15. Metz DP, Hingorani M, Calder VL et al. (1997): T-cell cytokines in chronic allergic eye disease. J Allergy Clin Immunol 100: 817-824.
16. Bailey CS & Buckley RJ: Nedocromil sodium in contact lenses associated papillary conjunctivitis. Eye 1993; Supplement 29-33.
17. Freidlaender MH & Howes J (1997): A double-masked placebo-controlled evaluation of the efficacy and safety of Loteprednol Etabonate in the treatment of giant papillary conjunctivitis. Am J Ophthalmol 123: 445-464.